High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial).

Authors :: Dhooria S
Chaudhary S
Sehgal IS
Agarwal R
Arora S
Garg M
Prabhakar N
Puri GD
Bhalla A
Suri V
Yaddanapudi LN
Muthu V
Prasad KT
Aggarwal AN
Source :: The European respiratory journal [Eur Respir J] 2022 Feb 17; Vol. 59 (2). Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).
Publication Year :: 2022
Abstract: Competing Interests: Conflict of interest: None declared.

Subjects :: Humans
Lung
Respiration, Artificial
SARS-CoV-2
Treatment Outcome
COVID-19
Prednisolone

Full Text Access

Tools